Vitamin D is technically a hormone precursor — it functions as a steroid hormone after two sequential hydroxylation steps (liver then kidney), activating vitamin D receptors (VDR) in virtually every tissue in the body. VDR receptors regulate expression of 200–2000 genes involved in immune function, cell differentiation, calcium metabolism, inflammation, and neurological function. This breadth of action explains why vitamin D deficiency is associated with such a wide range of health outcomes — and why it is the most consequential nutritional deficiency in the developed world.
The critical distinction that most supplement guidance misses: the goal of vitamin D supplementation is not to reach the "normal" lab range (20–50 ng/mL on most lab reports) — it is to reach the evidence-supported optimal range (40–60 ng/mL). Most people who take 600–1000 IU/day remain below 30 ng/mL. Reaching and sustaining 40–60 ng/mL requires testing (a 25-OH-D blood test, widely available, often included in standard blood panels), adequate D3 dose (typically 2000–5000 IU/day depending on baseline), and co-supplementation with magnesium (required for D3 activation) and K2 (to safely direct the increased calcium absorption to bone rather than soft tissue).
Magnesium is required for both hydroxylation steps that convert vitamin D3 into its active hormone form (1,25-dihydroxyvitamin D / calcitriol): the liver 25-hydroxylase step and the kidney 1α-hydroxylase step both depend on magnesium-dependent enzymes.
Approximately 50–80% of Americans are magnesium insufficient. If magnesium is deficient, vitamin D supplementation may have minimal effect because the conversion to active calcitriol is blocked — this may explain why some people report no benefit from vitamin D supplementation despite adequate doses.
Uwitonze 2018 (Journal of the American Osteopathic Association): magnesium supplementation restored vitamin D effectiveness in magnesium-deficient individuals. Always supplement vitamin D with adequate magnesium — magnesium glycinate or malate 200–400mg/day.
Vitamin D increases intestinal calcium absorption by 30–40%. This calcium must be directed to bone (the desired outcome) rather than to arteries, joints, and soft tissue (calcification — the undesired outcome). Vitamin K2 activates two calcium-routing proteins: osteocalcin (directs calcium into bone matrix) and matrix GLA protein (MGP, prevents arterial calcification).
K2 MK-7 (menaquinone-7, from fermented foods like natto) is preferred over K2 MK-4 (shorter half-life; requires multiple daily doses). Standard dose: 90–200mcg MK-7/day alongside vitamin D supplementation.
The "D3 + K2" combination is a well-reasoned stack — D3 raises calcium absorption efficiency; K2 ensures that calcium goes to bone. Both together provide the bone density benefit of D3 without the calcification risk of high-dose D3 without K2.
| Level (ng/mL) | Classification | Clinical Significance | Action |
|---|---|---|---|
| <12 | Severe deficiency | Risk of rickets (children), osteomalacia, severe immune compromise, myopathy; this level indicates complete vitamin D system failure | High-dose repletion (physician supervised): 50,000 IU weekly × 8–12 weeks (prescription D2 or D3), then maintenance dose; retest in 3 months |
| 12–20 | Deficiency | Impaired bone mineralization, reduced immune function, increased fall risk in elderly, associated with higher depression and cardiovascular risk in epidemiological studies | 2000–4000 IU D3/day; retest in 3 months to assess response; add magnesium and K2 |
| 20–30 | "Insufficient" (IOM: "adequate") | Bone disease prevented; immune, cognitive, and cancer-related benefits are submaximal; most lab reference ranges incorrectly show this as "normal" | 2000–3000 IU D3/day to raise toward 40–60 ng/mL optimal target; retest in 3 months |
| 30–40 | Adequate (mainstream threshold) | Adequate for most skeletal outcomes; below evidence-optimal range for non-skeletal benefits; many people on standard supplementation plateau here | Increase to 3000–4000 IU/day to reach optimal 40–60 ng/mL if targeting optimal range |
| 40–60 | Optimal (evidence-supported) | Associated with lowest all-cause mortality risk in observational data; optimal immune, cognitive, and metabolic outcomes; achievable with 2000–5000 IU/day depending on individual | Maintain current dose; retest annually |
| 60–100 | High-normal / caution zone | Generally safe; some evidence of diminishing returns or U-shaped curve above 60 ng/mL; benefits vs bone health optimal at 40–60 ng/mL | Reduce dose slightly; retest in 3 months |
| >100–150 | Toxicity risk | Hypercalcemia risk (nausea, vomiting, weakness, polyuria, nephrocalcinosis); only achievable with sustained very high-dose supplementation (typically >10,000 IU/day for months) | Stop supplementation; physician evaluation; hypercalcemia treatment if symptomatic |
Without blood testing (general maintenance): 2000–3000 IU D3/day with fat-containing meal (fat-soluble vitamin — absorption increases 32–50% with dietary fat); add magnesium glycinate 200–400mg/day; add K2 MK-7 100–200mcg/day; this dose is safe for most adults long-term (Endocrine Society upper limit 4000 IU; this is a conservative, tolerable buffer below the upper limit).
With blood testing (targeted approach): Test 25-OH-D before starting; if below 30 ng/mL: start 4000–5000 IU/day with cofactors; retest in 3 months; if 30–40 ng/mL: 3000–4000 IU/day; retest in 3 months; target 40–60 ng/mL; once at optimal range, reduce to 2000–3000 IU/day maintenance; test annually to ensure stability.
Obese individuals (BMI >30): Vitamin D is sequestered in adipose tissue — most studies show obese individuals require 2–3× the dose of lean individuals to achieve equivalent serum levels; start at 5000–6000 IU/day; testing is more important in this population because the dose-response relationship is less predictable.
Sun exposure reality: 15–20 minutes of midday sun (11am–2pm) on arms and legs produces approximately 2000–3000 IU of vitamin D3 in light-skinned individuals at latitudes below 37°N; production is zero above 37°N during winter months (UVB angle too low); darker skin requires 3–6× longer sun exposure for equivalent production; sunscreen (SPF 30+) reduces production by ~97%; for most people in modern indoor lifestyles, supplementation is necessary regardless of latitude.
As an Amazon Associate, StackProtocol earns from qualifying purchases made through links on this page. This does not affect the price you pay.